Research progress of 1,2-diIinoIeyIoxy-3-dimethy Iaminopropane-based cat-ionic Iipid nanoparticIe / 中国药科大学学报
Journal of China Pharmaceutical University
; (6): 112-117, 2016.
Article
em Zh
| WPRIM
| ID: wpr-491983
Biblioteca responsável:
WPRO
ABSTRACT
Cationic lipid nanoparticles possessing favorable biocompatibility and controllable particle size has at-tracted increasing attention in the field of non-viral vectors for delivering nucleic acids in vitro and in vivo.1,2-Dilinoleyloxy-3-dimethylaminopropane(DLinDMA)and its derivatives,one of the most important cationic lipid materials,have been widely studied as the mainly composition of cationic lipid nanoparticels.This paper summa-rized the structure,characteristics and clinical application of DLinDMA nanoparticles.
Texto completo:
1
Base de dados:
WPRIM
Idioma:
Zh
Revista:
Journal of China Pharmaceutical University
Ano de publicação:
2016
Tipo de documento:
Article